Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy

@article{BenMenachem2010EslicarbazepineAA,
  title={Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy},
  author={Elinor Ben-Menachem and Alberto Alain Gabbai and Andreas Hufnagel and Jusimara Maia and Patr{\'i}cio Soares-da-Silva},
  journal={Epilepsy Research},
  year={2010},
  volume={89},
  pages={278-285}
}
OBJECTIVE To investigate the efficacy and safety of once-daily eslicarbazepine acetate (ESL) when used as add-on treatment in adults with > or = 4 partial-onset seizures per 4-week despite treatment with 1 to 3 antiepileptic drugs (AEDs). METHODS This double-blind, parallel-group, multicenter study consisted of an 8-week observational baseline period, after which patients were randomized to placebo (n=100) or once-daily ESL 400 mg (n=96), 800 mg (n=101), or 1200 mg (n=98). Patients then… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 64 CITATIONS, ESTIMATED 36% COVERAGE

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.

  • Brain : a journal of neurology
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Update on treatment of partial onset epilepsy: role of eslicarbazepine

  • Neuropsychiatric disease and treatment
  • 2010
VIEW 8 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019